The latest amendment to the US Biosafety Act removes drug-resistant organisms

On September 25th, according to the official website of the US Congress, on September 23rd local time, there was another progress in the legislation of the US Biosafety Act. In the latest amendment, WuXi Biologics has been removed, but WuXi AppTec, BGI, BGI and its subsidiary Complete Genomics are still listed. At the same time, the plan is to be renamed the "Prohibition of Foreign Access to US Genetic Information Act", and will further focus on human data-related business. For the aforementioned changes, on September 25th, WuXi Biologics said it had no response yet.